Dichloromethane (DCM), also known as methylene chloride, is a volatile organic compound with several health effects upon exposure. Acute exposure to DCM primarily affects the central nervous system. Inhalation can lead to symptoms such as dizziness, headache, nausea, and fatigue. High concentrations may cause more severe effects like confusion, loss of consciousness, and even death due to respiratory depression.
Chronic exposure to DCM can result in more persistent health issues. Prolonged inhalation may lead to liver and kidney damage, as these organs are involved in metabolizing the compound. There is also evidence suggesting that DCM exposure can affect the cardiovascular system, potentially leading to arrhythmias or other heart-related issues.
DCM is metabolized in the body to carbon monoxide, which can bind to hemoglobin and form carboxyhemoglobin, reducing the blood's oxygen-carrying capacity. This can exacerbate symptoms of hypoxia, particularly in individuals with pre-existing cardiovascular or respiratory conditions.
The International Agency for Research on Cancer (IARC) classifies DCM as a Group 2A carcinogen, meaning it is probably carcinogenic to humans. Animal studies have shown an increased incidence of liver and lung cancer with DCM exposure, and there is some evidence of an association with cancer in humans, particularly bile duct cancer.
Skin contact with DCM can cause irritation and dermatitis, as it is a defatting agent. Eye exposure may result in irritation and corneal damage.
Overall, the health effects of DCM exposure depend on the concentration and duration of exposure, with both acute and chronic effects posing significant health risks. Proper safety measures, including adequate ventilation and personal protective equipment, are essential to minimize these risks.